BRAFV600E-mutated ovarian serous borderline tumors are at relatively low risk for progression to serous carcinoma

M. Herman Chui, Susanne K. Kjaer, Kirsten Frederiksen, Charlotte G. Hannibal, Tian Li Wang, Russell Vang, Ie Ming Shih

Research output: Contribution to journalArticle

Fingerprint Dive into the research topics of 'BRAF<sup>V600E</sup>-mutated ovarian serous borderline tumors are at relatively low risk for progression to serous carcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences